Form 4: Calix CEO Exercises Options, Sells Shares Under 10b5-1 Plan

Calix President and CEO Michael Weening exercised stock options and subsequently sold 126,000 shares of common stock under a pre-arranged trading plan.

Summary

• Michael Weening, President & CEO and Director of Calix, Inc., engaged in a pre-planned transaction involving company stock.
• On August 28, 2025, Mr. Weening exercised stock options to acquire 126,000 shares of common stock at an exercise price of $7.84 per share.
• Immediately following the option exercise on the same date, Mr. Weening sold 126,000 shares of common stock at a price of $60.00 per share.
• The sales were conducted pursuant to a Rule 10b5-1 trading plan, which was adopted on February 28, 2025.
• The stock options exercised were fully vested and exercisable as of November 27, 2023, and have an expiration date of November 27, 2029.
• Following these transactions, Mr. Weening directly owns 16,117 shares of common stock and 474,000 derivative securities (stock options).

Sentiment

Score: 5

Explanation: The filing reports a pre-planned insider transaction, which is a routine event for executives managing their personal portfolios and does not inherently signal positive or negative company performance or strategic shifts.

Positives

• The transaction demonstrates the CEO realizing value from previously granted stock options, indicating a successful vesting period and appreciation in the company's stock price since the options were granted.
• The use of a Rule 10b5-1 trading plan indicates a pre-scheduled and transparent transaction, reducing concerns about opportunistic insider selling.

Negatives

• The sale of a significant number of shares by a key executive, even if pre-planned, could be perceived by some investors as a lack of conviction in the company's near-term growth prospects, although this is often a routine personal financial management decision.

Future Outlook

This Form 4 filing reports historical insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

Insider transactions, particularly those involving the exercise of stock options and subsequent sales, are common occurrences for executives in publicly traded companies. The use of a Rule 10b5-1 trading plan is a standard practice to allow insiders to sell shares in a pre-arranged manner, mitigating potential accusations of trading on material non-public information. This transaction is consistent with typical executive compensation and personal financial management strategies within the technology sector.

Stakeholder Impact

• Shareholders: The sale of shares by the CEO could lead to minor short-term sentiment shifts, but the pre-planned nature under Rule 10b5-1 typically limits significant impact.
• Employees: No direct impact on employees is indicated by this transaction.

Key Dates

Recommendation

The Form 4 details a pre-scheduled insider transaction by the CEO, which is a routine event for executives managing their personal portfolios. It does not provide new information about the company's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Investors should continue to evaluate Calix based on its fundamental business performance and market position.

Keywords

Calix, CALX, Michael Weening, Insider Trading, Stock Option Exercise, Share Sale, Form 4, 10b5-1 Plan, CEO Stock Transaction, Executive Compensation